Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026)

Korro Bio (KRRO) has 7 years of Other Accumulated Expenses data on file, last reported at $175000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 64.5% year-over-year to $175000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175000.0 (down 64.5% YoY) and the FY2025 annual result came in at $70000.0, down 74.73% from the prior year.
• Other Accumulated Expenses grew to $175000.0 in Q1 2026, from $70000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $493000.0 in Q1 2025 to a low of $70000.0 in Q4 2025.
• A 5-year average of $231583.3 and a median of $196500.0 in 2022 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 252.14% in 2025, down 74.73% in 2025.
• Tracing KRRO's Other Accumulated Expenses over 5 years: stood at $207000.0 in 2022, then jumped by 115.94% to $447000.0 in 2023, then tumbled by 38.03% to $277000.0 in 2024, then sank by 74.73% to $70000.0 in 2025, then soared by 150.0% to $175000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $175000.0 (Q1 2026), $70000.0 (Q4 2025), and $111000.0 (Q3 2025), per Business Quant data.